Cartesian Therapeutics (RNAC) Proxy Filing summary

Executive summary

• Annual meeting scheduled for June 13, 2025, with virtual participation available for shareholders.

• Shareholders are encouraged to review proxy materials and vote by June 12, 2025, 11:59 PM ET.

Voting matters and shareholder proposals

• Election of three directors: Timothy C. Barabe, Carsten Brunn, and Nishan de Silva.

• Advisory vote on executive compensation for named executive officers.

• Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2025.

• Provision for other business to be transacted as may properly come before the meeting.

Board of directors and corporate governance

• Board recommends voting in favor of all director nominees and proposals.